P3 AD Adult Monotherapy Study 1
Research payments
$790,033
Through program year 2023, $790,033 in research payments was reported against P3 AD Adult Monotherapy Study 1, across 53 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $790,033 | 53 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Catherine Pointon Charlotte, NC Named on 2 payments
- Stephen Schleicher Sugarloaf, PA Named on 2 payments
- Howard Sofen Los Angeles, CA Named on 2 payments
- David Rodriguez Miami, FL Named on 2 payments
- Sadra Jazayeri Phoenix, AZ Named on 2 payments
- Rosalyn George Wilmington, NC Named on 2 payments
- Elliot Shin Las Vegas, NV Named on 2 payments
- Jarad Levin Oklahoma City, OK Named on 1 payment
- Linda Stein Gold West Bloomfield, MI Named on 1 payment
- Michael Lin Sherman Oaks, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.